.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
AstraZeneca
Medtronic
Express Scripts
QuintilesIMS
Harvard Business School
Dow
UBS
Cipla
Colorcon

Generated: September 19, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Use of granisetron for the treatment of postoperative nausea and vomiting
Abstract:The present invention is directed to a method for the treatment of post-operative nausea and vomiting wherein granisetron is administered to a patient in need thereof.
Inventor(s): Sanger; Gareth John (Sawbridgeworth, GB), Davey; Philip Timothy (Bishop's Stortford, GB), Dott; Christopher Stuart (Reigate, GB)
Assignee: SmithKLine Beecham p.l.c. (Brentford, GB)
Application Number:08/525,521
Patent Claims: 1. A method of treatment of post-operative nausea and vomiting (PONV) in mammals, including man, by administration of granisetron to the mammal in need thereof.

2. A method according to claim 1 wherein the granisetron is adapted for intravenous administration.

3. A method according to claim 1 wherein granisetron is administered in a 1 mg to 3 mg unit dose.

4. A method according to claim 1 wherein granisetron is administered pre-operatively, peri-operatively; or post-operatively.

5. A method according to claim 4 wherein granisetron is administered pre-operatively.

6. The method of claim 1 wherein from about 1 mg to about 3 mg of granisetron is administered pre-operatively.

7. The method of claim 1 wherein from about 1 mg to about 3 mg of granisetron is administered peri-operatively.

8. The method of claim 1 wherein from about 1 mg to about 3 mg of granisetron is administered post-operatively.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
AstraZeneca
Chubb
Johnson and Johnson
Baxter
Dow
Daiichi Sankyo
Medtronic
Federal Trade Commission
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot